It's the foundation of psychiatric diagnosis. And it's about to get a makeover

mental-health

The American Psychiatric Association (APA) is planning a major overhaul of the DSM-5, the Diagnostic and Statistical Manual of Mental Disorders known in the field as “the Bible of psychiatry.” Instead of a weighty volume, the next DSM will be “a living document” online and easier to update. The APA hasn’t set a strict timeline and hasn’t decided yet if it will be called the DSM-6 or some new name.

The DSM is used by psychiatrists, psychologists, physicians, researchers, and insurance companies. In the past, the DSM has been revised every 15 years or so, with the DSM-5 published in 2013. The lengthy process and print-only format has had limitations: clinicians and other stakeholders may lack uniform and timely access to the most current evidence. Keeping the next edition primarily online means it can be updated more regularly to reflect recent scientific developments in diagnosis and treatment.

One major critique addressed in the revision is that the current DSM doesn’t reference the underlying causes of mental disorders. Since the DSM-5 acknowledged potential causes under “Risk and Prognostic Factors,” the new edition will emphasize this more prominently. Factors like living in poverty, exposure to environmental toxins, or being part of a religious or cultural minority facing additional daily stressors can all affect mental health negatively. Future DSMs will outline approaches to prevention of symptoms in different populations—a “sea change in psychiatry.”

Since the DSM-5’s publication, there have been significant advances in understanding biological roots of mental health disorders. Scientists are closer to discovering biological markers for various disorders, including blood tests, neuro imaging tests, and digital tests from wearable devices. The FDA has already approved tests for biomarkers in Alzheimer’s disease. Another area is inflammation markers for major depression—a subset of people with clinical depression have elevated measures of inflammation that can be picked up by a blood test of C-reactive protein.

The APA is seeking input from a broad range of health care professionals and people with lived experience of psychiatric conditions.


This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.npr.org/2026/01/28/nx-s1-5684121/dsm-5-american-psychiatric-association-diagnostic-mental-health